237 related articles for article (PubMed ID: 22266946)
61. Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
Jarrad AM; Ang CW; Debnath A; Hahn HJ; Woods K; Tan L; Sykes ML; Jones AJ; Pelingon R; Butler MS; Avery VM; West NP; Karoli T; Blaskovich MAT; Cooper MA
J Med Chem; 2018 Dec; 61(24):11349-11371. PubMed ID: 30468386
[TBL] [Abstract][Full Text] [Related]
62. A novel indigoid anti-tuberculosis agent.
Klein LL; Petukhova V; Wan B; Wang Y; Santasiero BD; Lankin DC; Pauli GF; Franzblau SG
Bioorg Med Chem Lett; 2014 Jan; 24(1):268-70. PubMed ID: 24314672
[TBL] [Abstract][Full Text] [Related]
63. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
64. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
65. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
66. Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.
Popovici C; Pavel CM; Sunel V; Cheptea C; Dimitriu DG; Dorohoi DO; David D; Closca V; Popa M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830021
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and biological evaluation against Mycobacterium tuberculosis and Leishmania amazonensis of a series of diaminated terpenoids.
Dos Reis DB; Souza TCA; Lourenço MCS; de Almeida MV; Barbosa A; Eger I; Saraiva MF
Biomed Pharmacother; 2016 Dec; 84():1739-1747. PubMed ID: 27876209
[TBL] [Abstract][Full Text] [Related]
68. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M
Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962
[TBL] [Abstract][Full Text] [Related]
69. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
70. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
[TBL] [Abstract][Full Text] [Related]
71. 1-Chloro-2-formyl indenes and tetralenes as antitubercular agents.
Chanda D; Saikia D; Kumar JK; Thakur JP; Agarwal J; Chanotiya CS; Shanker K; Negi AS
Bioorg Med Chem Lett; 2011 Jul; 21(13):3966-9. PubMed ID: 21641212
[TBL] [Abstract][Full Text] [Related]
72. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
[TBL] [Abstract][Full Text] [Related]
73. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.
Manjunatha UH; Boshoff H; Dowd CS; Zhang L; Albert TJ; Norton JE; Daniels L; Dick T; Pang SS; Barry CE
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):431-6. PubMed ID: 16387854
[TBL] [Abstract][Full Text] [Related]
74. New Non-Toxic Semi-Synthetic Derivatives from Natural Diterpenes Displaying Anti-Tuberculosis Activity.
Matos PM; Mahoney B; Chan Y; Day DP; Cabral MM; Martins CH; Santos RA; Bastos JK; Page PC; Heleno VC
Molecules; 2015 Oct; 20(10):18264-78. PubMed ID: 26457701
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3947-50. PubMed ID: 21641797
[TBL] [Abstract][Full Text] [Related]
76. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
77. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
[TBL] [Abstract][Full Text] [Related]
78. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.
Mohan SB; Ravi Kumar BV; Dinda SC; Naik D; Prabu Seenivasan S; Kumar V; Rana DN; Brahmkshatriya PS
Bioorg Med Chem Lett; 2012 Dec; 22(24):7539-42. PubMed ID: 23122523
[TBL] [Abstract][Full Text] [Related]
79. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Kmentova I; Sutherland HS; Palmer BD; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
J Med Chem; 2010 Dec; 53(23):8421-39. PubMed ID: 21069962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
